标题 |
A Phase IIa Randomized, Placebo-Controlled, Double-Blind (Sponsor Open) Study to Investigate the Clinical Efficacy, Safety, and Tolerability of Nemiralisib (GSK2269557) in Symptomatic COPD Participants with a History of Exacerbations (205739)
一项IIa期随机、安慰剂对照、双盲(申办方开放)研究,旨在调查Nemiralisib(GSK2269557)在有恶化史的症状性COPD受试者中的临床疗效、安全性和耐受性(205739)
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 | 作者:Nl, Omon |
求助人 | |
下载 | 暂无链接,等待应助者上传 |